Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.

Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O'Malley SS.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):1-8. doi: 10.1016/j.drugalcdep.2010.04.021. Epub 2010 Jun 19.

2.

Opioid antagonists for smoking cessation.

David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ.

Cochrane Database Syst Rev. 2013 Jun 6;(6):CD003086. doi: 10.1002/14651858.CD003086.pub3. Review.

3.

Opioid antagonists for smoking cessation.

David S, Lancaster T, Stead LF, Evins AE.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003086. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD003086.

PMID:
17054160
4.

Opioid antagonists for smoking cessation.

David S, Lancaster T, Stead LF.

Cochrane Database Syst Rev. 2001;(3):CD003086. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003086.

PMID:
11687036
5.

Electronic cigarettes for smoking cessation and reduction.

McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P.

Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Review.

PMID:
25515689
6.

Interventions for preventing weight gain after smoking cessation.

Farley AC, Hajek P, Lycett D, Aveyard P.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3. Review.

PMID:
22258966
7.

Systematic review and meta-analysis of opioid antagonists for smoking cessation.

David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ.

BMJ Open. 2014 Mar 14;4(3):e004393. doi: 10.1136/bmjopen-2013-004393. Review.

8.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200
9.

Nicotine replacement therapy for smoking cessation.

Silagy C, Mant D, Fowler G, Lancaster T.

Cochrane Database Syst Rev. 2000;(3):CD000146. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD000146.

PMID:
10908462
10.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
11.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
12.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Lancaster T.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD000146.

PMID:
18253970
14.

Nicotine replacement therapy for smoking cessation.

Silagy C, Mant D, Fowler G, Lancaster T.

Cochrane Database Syst Rev. 2000;(2):CD000146. Review. Update in: Cochrane Database Syst Rev. 2000;(3):CD000146.

PMID:
10796494

Supplemental Content

Support Center